[HTML][HTML] Ex Vivo Tools and Models in MASLD Research
RI Velliou, E Giannousi, C Ralliou, E Kassi… - Cells, 2024 - pmc.ncbi.nlm.nih.gov
Metabolic dysfunction-associated fatty liver disease (MASLD) presents a growing global
health challenge with limited therapeutic choices. This review delves into the array of ex vivo …
health challenge with limited therapeutic choices. This review delves into the array of ex vivo …
[HTML][HTML] Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
L Zhao, H Tang, Z Cheng - Pharmaceuticals, 2024 - mdpi.com
Liver fibrosis is a progressive scarring process primarily caused by chronic inflammation and
injury, often closely associated with viral hepatitis, alcoholic liver disease, metabolic …
injury, often closely associated with viral hepatitis, alcoholic liver disease, metabolic …